Nosopharm develops novel antimicrobial drugs for the treatment of bacterial infections.
Business Model:
Revenue: $5M
Employees: 2-10
Address: 21 avenue Georges Pompidou
City: Lyon Cedex
State: rhône alpes
Zip: 69486
Country: FR
Nosopharm develops novel antimicrobial drugs for the treatment of bacterial infections.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 11/2013 | Venture Round | 3 | $1.2M |
Alto Invest Auriga Partners KREAXI Alto Invest Auriga Partners KREAXI |
3/2017 | Venture Round | $0 |
Alto Invest Auriga Partners KREAXI Alto Invest Auriga Partners KREAXI |
2/2018 | Debt | $1.2M |
Bpifrance |
10/2013 | Grant | $1.2M | 3/2017 | Equity | $2.6M |
Auriga Partners Kreaxi Alto Invest |
2/2018 | Debt Financing | 1 | $1.2M |
Bpifrance Bpifrance |
3/2017 | Venture Round | 3 | $2.6M |
Alto Invest Auriga Partners KREAXI Alto Invest Auriga Partners KREAXI |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|